Skip to content
This GLP
← Research
Safety

Aspiration pneumonia after thrombectomy: eleven cases, one clear warning

Patients on a GLP-1 arriving for emergency stroke treatment had more aspiration pneumonia. Their recovery at 90 days was no worse, and the authors say treat anyway.

Glenn Torres6 min read
Aspiration pneumonia within 30 dayson a GLP-1 (n = 41)26.8%not on one (n = 699)10.3%90-day functional outcome: no difference.26.8% of 41 patients is eleven pneumonias.

These drugs slow gastric emptying, which is why an elective procedure comes with instructions about holding them, as set out in what to tell the anesthesiologist. A stroke gives no such notice. A single-center cohort looked at what happens when someone on one of these drugs arrives needing emergency thrombectomy, with a full stomach nobody had the opportunity to empty [1].

Of 740 consecutive patients, 41 were on a GLP-1 drug at presentation. Aspiration pneumonia within 30 days occurred in 26.8% of them against 10.3% of the rest, an absolute difference of 16.5 percentage points, with a propensity-matched adjusted odds ratio of 3.25 (95% CI 1.43–7.40).

The size of the exposed group deserves stating plainly. Twenty-six point eight percent of 41 patients is eleven pneumonias, and every estimate in this study rests on them. That is why the confidence interval spans from 1.43 to 7.40 — the direction is reasonably clear and the magnitude is not, and a single-center series of this size cannot narrow it further. The same caution applies to any estimate built on a handful of rare events, as in the overdose comparison.

Two outcomes did not move, and they are the ones a stroke patient would ask about first. Symptomatic intracranial hemorrhage occurred in 4.9% against 9.1%, with an interval so wide it establishes nothing in either direction, and 90-day functional outcomes on the modified Rankin Scale were effectively identical. A complication rose; recovery did not visibly suffer. That combination is consistent with pneumonia being a real but manageable problem in this setting.

The mechanism is the same one behind the elective-surgery guidance and behind the motility findings in the gastroparesis evidence, but the situation is different in the one way that matters: nothing can be held in advance. The practical implication is for the hospital rather than the patient, which distinguishes it from most of what this site covers — though it is one more entry in the pattern of these drugs quietly changing outcomes in procedures they have nothing to do with, as in the shoulder surgery signals.

Frequently asked

Should someone on a GLP-1 avoid emergency stroke treatment?
No, and the authors say so explicitly. Thrombectomy should not be withheld on the basis of GLP-1 exposure. The finding supports aspiration precautions during and after the procedure.
How solid is the finding?
Directionally reasonable, imprecise in size. Only 41 patients were exposed and the result rests on eleven pneumonias, which is why the odds ratio interval runs from 1.43 to 7.40.
Did outcomes after the stroke get worse?
Not measurably. Symptomatic intracranial hemorrhage and 90-day functional scores showed no significant differences between the groups.

Sources

  1. [1] Sardana S, Mateti N, Hackett CT, Singh R, et al. (2026). GLP-1 receptor agonist use and aspiration pneumonia risk following endovascular thrombectomy Journal of NeuroInterventional Surgery. PMID 42248677

More in Safety